Find2Cure (F2C) Precision Medicine

F2C NGS is a tissue-based comprehensive genomic profiling (CGP) test that assesses DNA and RNA in solid tumors and has been clinically and analytically validated. The test is designed to work with small tumor tissue samples so that more patients will benefit from precision medicine. Microsatellite instability (MSI) and tumor mutational burden (TMB) are included in any test outcome to aid in immunotherapy decisions.

Both solid and aggressive tumors are protected by F2C NGS for qualified Insured patients.

Tap here to see the gene list.

Exceptional Results

With a median turnaround period of 7 business days, this commercial comprehensive test has the smallest sample size specifications of any commercial comprehensive test.

Insights into Cancer

For clinical trials in solid tumors, a single test that analyses both guideline-recommended genes and emerging biomarkers.

Excellent Decision-Making

A simplified test report allows for fast and confident decision-making.

WHAT IS THE DIFFERENCE BETWEEN OUR TEST AND OTHERS?

F2C-NGS produces outcomes for a greater number of patients by using less tissue. Other leading CGP tests may not be able to be performed on 1 in 2 patients with advanced cancer. F2C-NGS uses a fraction of the tissue used for other tests, allowing 50 percent or more patients to benefit from precision medicine.

With F2C NGS, up to 50% more patients can be screened.

For other leading NGS studies, of samples met tumor tissue requirements (25mm2)
while for F2C NGS, of samples met tumor tissue requirements (0.5mm2).

FOCUS

We employ state of the art genomics technologies ranging from Microarray, Sanger Sequencing to Next Generation Sequencing to decode the underlying variants in the genome and transcriptome and use the technology to evolve as GENE-Drug match company.

NGS HotSpot

Next-Generation Sequencing (NGS) panels allow investigation of multiple genes simultaneously in situations where there is phenotypic overlap across disorders.

Microarray

A DNA microarray is a collection of microscopic DNA spots attached to a solid surface which is used to measure the expression levels of large numbers of genes simultaneously.

RT-PCR

RT-PCR is a PCR test that is designed to detect and measure RNA. Although initial PCR tests amplified DNA, many viruses and other biological components (for example, mitochondria) utilize RNA as their genetic material.

NGS

GENOME & Transcriptome Mapping

Medical Informatics

Patients NGS DATA

Treatment Plans

Precision & Personalized Treatment

F2C NGS

A rigorous genomic profiling test that requires minimal tumor tissue.